Amygdala opioid receptors mediate the electroacupuncture-induced deterioration of sleep disruptions in epilepsy rats by Pei-Lu Yi et al.
Yi et al. Journal of Biomedical Science 2013, 20:85
http://www.jbiomedsci.com/content/20/1/85RESEARCH Open AccessAmygdala opioid receptors mediate the
electroacupuncture-induced deterioration
of sleep disruptions in epilepsy rats
Pei-Lu Yi1,2, Chin-Yu Lu1, Chiung-Hsiang Cheng1, Yi-Fong Tsai1, Chung-Tien Lin1* and Fang-Chia Chang1,3,4*Abstract
Background: Clinical and experimental evidence demonstrates that sleep and epilepsy reciprocally affect each other.
Previous studies indicated that epilepsy alters sleep homeostasis; in contrast, sleep disturbance deteriorates epilepsy. If a
therapy possesses both epilepsy suppression and sleep improvement, it would be the priority choice for seizure
control. Effects of acupuncture of Feng-Chi (GB20) acupoints on epilepsy suppression and insomnia treatment have
been documented in the ancient Chinese literature, Lingshu Jing (Classic of the Miraculous Pivot). Therefore, this study
was designed to investigate the effect of electroacupuncture (EA) stimulation of bilateral Feng-Chi acupoints on sleep
disruptions in rats with focal epilepsy.
Results: Our result indicates that administration of pilocarpine into the left central nucleus of amygdala (CeA) induced
focal epilepsy and decreased both rapid eye movement (REM) sleep and non-REM (NREM) sleep. High-frequency
(100 Hz) EA stimulation of bilateral Feng-Chi acupoints, in which a 30-min EA stimulation was performed before the
dark period of the light:dark cycle in three consecutive days, further deteriorated pilocarpine-induced sleep disruptions.
The EA-induced exacerbation of sleep disruption was blocked by microinjection of naloxone, μ- (naloxonazine),
κ- (nor-binaltorphimine) or δ-receptor antagonists (natrindole) into the CeA, suggesting the involvement of
amygdaloid opioid receptors.
Conclusion: The present study suggests that high-frequency (100 Hz) EA stimulation of bilateral Feng-Chi acupoints
exhibits no benefit in improving pilocarpine-induced sleep disruptions; in contrast, EA further deteriorated sleep
disturbances. Opioid receptors in the CeA mediated EA-induced exacerbation of sleep disruptions in epileptic rats.
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Clinical and experimental observations have demonstrated
that sleep and epilepsy reciprocally affect each other. While
rapid eye movement (REM) sleep suppresses seizure activ-
ity, non-REM (NREM) sleep facilitates it [1,2]. On the
other hand, patients with epilepsy experience more day-
time sleepiness compared with control patients [3], and
children with epilepsy experience poor quality of sleep,
anxiety about sleep, and sleep-disordered breathing [4].
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reproduction in any medium, provided the orof epilepsy at different zeitgeber time points results in dif-
ferent sleep disruptions by altering either the homeostatic
factors or circadian rhythm of the sleep-wake regulation in
rats [5,6]. Notably, epilepsy-induced sleep disruptions fur-
ther deteriorate and worsen seizure control [7]. Therefore,
if a therapy possesses both epilepsy suppression and im-
provement of sleep disturbance, it becomes the most ap-
propriate therapy for seizure control.
Acupuncture has been used as an alternative medicine
to treat patients with chronic pain [8] (e.g., migraines,
tension-type headache and peripheral joint osteoarthritis
[9]) by manipulating thin needles and inserting into acu-
points. Electroacupuncture (EA) is a modified form of
acupuncture, which is performed by passing an electrical
current through needles into the acupoints and controls
the acupuncture dose by modifying the frequency andhis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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documented in some Chinese literatures indicating
the therapeutic effect in epilepsy, insomnia, and other
neurological diseases, in addition to pain relief. For ex-
ample, the acupoints of Feng-Chi (GB20) has indications
of epileptic suppression and insomnia, documented in
the Lingshu Jing (Classic of the Miraculous Pivot). How-
ever, there is a lack of scientific evidence to elucidate its
underlying mechanism and to prove the clinical efficacy.
Our observation demonstrated that 100 Hz EA stimula-
tion of bilateral Feng-Chi acupoints exacerbates focal
epilepsy induced by administering pilocarpine into the
left central nucleus of amygdala (CeA). However, the
effect of 100 Hz EA stimulation of bilateral Feng-Chi
acupoints on sleep disturbances in rats with focal epi-
lepsy has not been investigated. Previous studies have
demonstrated that EA stimulation of bilateral Anmian
(EX17) acupoints enhances sleep through the activa-
tion of vagus nerve, which subsequently activates opi-
oid receptors in the nucleus of tractus solitarius (NTS)
[10,11]. Feng-Chi acupoint is anatomically close to the
Anmian acupoint. It has been indicated that amygdala
receives the afferent projection from the NTS [12,13].
Altering NTS activity changes dynorphin gene expres-
sion in the amygdala [14]. Furthermore, amygdala plays
an important role in the sleep regulation [15–18], es-
pecially in REM sleep [16–18]. Therefore, stimulation of
Feng-Chi acupoints may activate vagus nerve and subse-
quently modify the opioid receptors in the amygdala to
achieve its effect in the sleep-wake regulation. This
current study was designed to elucidate the effect of high-
frequency (100 Hz) EA stimulation of Feng-Chi acupoints
in the sleep alterations induced by the amygdaloid focal
epilepsy.
Discovery of endogenous opioid peptides, including
β-endorphin, dynorphin, enkephalin and endomorphin,
in the central nervous system (CNS) reveals the mysteri-
ous actions of acupuncture, especially in its analgesic ef-
fect [19–21]. Han and his colleagues have shown that
endogenous opioids and distinct opioid receptors medi-
ate the analgesic effect induced by both low-frequency
and high-frequency EA stimuli [22,23]. While μ- and δ-
opioid receptors in the spinal cord are dominant in the
low-frequency EA-induced analgesia, κ-opioid receptors
contribute to the high-frequency EA effect [22,23]. Our
previous results also delineated that 10 Hz EA stimula-
tion of Anmian acupoints enhances NREM sleep through
activation of μ-opioid receptors in the caudal NTS [10],
whereas κ-receptors contribute to the 100 Hz EA-
induced sleep enhancement [11]. This study further elu-
cidated the involvement of CeA opioid receptors in sleep
alterations induced by high-frequency (100 Hz) EA stimu-
lation of bilateral Feng-Chi acupoints in rats with amygdal-
oid focal epilepsy.Methods
Pharmacological agents
Stock solutions of a broad-spectrum opioid antagonist
(naloxone hydrochloride (Tocris, Bristol, UK)), a μ-receptor
antagonist (naloxonazine dihydrochloride (Tocris)), a
δ-receptor antagonist (naltrindole hydrochloride (Tocris))
and a κ-receptor antagonist (nor-binaltorphimine dihy-
drochloride (Tocris)) were dissolved in pyrogen-free saline
(PFS). Pilocarpine (1 mg/1 μl, Sigma-Aldrich, St. Louis,
MO, USA) was also dissolved in PFS. The stock solutions
were stored at 4°C until use. Our previous results and
others indicated that the appropriate microinjection dos-
age for naloxonazine, naltrindole and nor-binaltorphimine
to selectively block μ-, δ- and κ-opioid receptors, without
interaction with other opioid receptor subtypes, is within
20 μg [10,11,24,25]. In current study, naloxone, naloxona-
zine, naltrindole and nor-binaltorphimine were microin-
jected at the dose of 10 μg/μl, which efficiently exhibits
their specific pharmacological blockade according to our
previous studies [10,11]. The total volume for each in-
jection was 1 μl and the duration of injection was 3 to
5 minutes. Our previous study has demonstrated that
microinjection of 1 μl solution into the CeA did not cause
CeA lesion [26].
Animals
Male Sprague-Dawley rats (250 - 300 g, 8-9 week old;
National Laboratory Animal Breeding and Research Cen-
ter, Taiwan) were used in this study. Rats were anesthetized
by intraperitoneal injection with 50 mg/kg Zoletil® (Virbac,
Carros, France). Rats were surgically implanted with three
electroencephalogram (EEG) screw electrodes as previously
described [27] and a microinjection guide cannulae di-
rected into the left CeA (AP, 2.8 mm from bregma; ML,
4.2 mm; DV, 7.8 mm relative to bregma). The coordinates
were adopted from the Paxinos and Watson rat atlas [28].
Two screw EEG electrodes were placed over the left frontal
and parietal lobes of cortices, and a third EEG electrode
was placed over the right cerebellum and served to ground
the animal to reduce signal artifacts. Insulated leads from
EEG electrodes were routed to a Teflon pedestal (Plastics
One, Roanoke, VA, USA). The Teflon pedestal was then
cemented to the skull with dental acrylic (Tempron, GC
Co., Tokyo, Japan). The incision was treated topically with
polysporin (polymixin B sulfate – bacitracin zinc) and the
animals were allowed to recover for seven days prior to the
initiation of experiments. The rats were housed sep-
arately in individual recording cages in the isolated room,
in which the temperature was maintained at 23 ± 1°C
and the light:dark (L:D) rhythm was controlled in a
12:12 h cycle (40 Watt x 4 tubes illumination). Food
(5001 rodent diet, LabDiet) and water were available
ad libitum. All procedures performed in this study were
approved by the National Taiwan University Animal Care
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periment Approval No. 95).
Experimental protocol
On the 2nd postsurgical day, the rats were connected to
the recording apparatus (see below) via a flexible tether.
As such, rats were allowed relatively unrestricted move-
ment within their own cages. One week after rats had
adapted to the 12:12-hour L:D cycle after surgery, a 24-
hour undisturbed baseline of the sleep-wake activity,
determined by the EEG and gross body movement (see
later), were obtained beginning at dark onset on the 1st
recording day in rats from all groups. Nine groups of
rats were used in the study as follows. Rats in group 1
(n = 6) received a 30-min 100 Hz EA stimulation of bi-
lateral Feng-Chi acupoints per day, beginning at 30 mi-
nutes before the dark period and performing in three
consecutive days (the EA group). Sleep-wake activity
was recorded right after the end of the last period of EA
stimuli and lasted for 24 hours. Rats in group 2 (n = 6)
were administered with pilocarpine into the left CeA
and the sleep-wake activity was recorded beginning from
the dark onset of the L:D cycle (the pilocarpine group).
In group 3 (n = 6), rats received the same EA stimulation
protocol as those rats in group 1 and were respectively
administered with PFS and pilocarpine into the CeA
before and after the last period of EA stimulation
(the PFS + EA + pilocarpine group). Rats in group 4 (n = 6)
were used to determine the effects of opioid receptor an-
tagonist, naloxone, on the 100 Hz EA-induced sleep alter-
ations in rats with focal epilepsy (the naloxone + EA +
pilocarpine group). Rats in groups 5 (n = 6), 6 (n = 6), and
7 (n = 6) were respectively used to depict the effects
of μ-receptor antagonist (naloxonazine, the naloxona-
zine + EA + pilocarpine group), δ-receptor antagonist
(naltrindole, the natrindole + EA + pilocarpine group) and
κ-receptor antagonist (nor-binaltorphimine, the nor-
binaltorphimine + EA + pilocarpine group) on the 100 Hz
EA-induced sleep alterations in rats with focal epilepsy.
Rats in groups 4-7 received the similar protocol as those
in group 3, except that naloxone (10 μg/μl), naloxonazine
(10 μg/μl), naltrindole (10 μg/μl) and nor-binaltorphimine
(10 μg/μl) were administered into the CeA before the last
period of EA stimulation in groups 4, 5, 6 and 7, respect-
ively. Rats in group 8 (n = 6) had the similar protocol as
those in group 3, except that rats received the sham EA
stimulation (the sham EA group, the sham EA stimulation
described later). Rats in group 9 (n = 9), used as the con-
trol group, received PFS, naloxone, naloxone + EA and na-
loxone + pilocarpine at the dark onset in three consecutive
days. When 100 Hz EA was given (see later), all rats were
lightly anesthetized with 29/4 mg/kg of ketamine/xylazine
(one third of the dose which we used for surgery in our
previous studies [10,11,27]), after which rat woke up in 30to 35 minutes. A 30-min period of EA stimulation was ad-
ministered before the onset of the dark period per day and
was applied in three consecutive days. The anesthetization
was given 30 minutes prior to the dark period and lasted
for 30 minutes. The 100 Hz EA stimulus was delivered via
the bilateral insertion of stainless needles (32 gauge x 1”,
Shanghai Yanglong Medical Articles Co.) on Feng-Chi
(GB20) acupoints in the depth of 2 mm. The stimulus
consisted of a train of biphasic pulses (150 μs duration
each) of 100 Hz with intensity of 1 mA, and was delivered
by Functions Electrical Stimulator (Trio 300, I.T.O., Japan).
The EA stimulation parameters are the same as we used in
the previous study [11]. The location of Feng-Chi acu-
points in the rat was determined by the same anatomical
location described in human. The acupoint of Feng-Chi
(GB 20) locates in the depression between the upper por-
tion of m. sternocleidomastoideus and m. trapezius in hu-
man. In rats, Feng-Chi acupoint locates 3 mm away
from the center of a line between two ears [29]. Sham
EA was performed by stimulation of a non-acupoint lo-
cated at the ventral conjunction between the forelimb and
the trunk as previously described [30]. Rats, anesthetized
by ketamine/xylazine, received same electrical stimuli, in-
cluding same intensity and frequency, but the stimulation
site did not locate at any acupoint.
Apparatus and recording
Signals from the EEG electrodes were fed into an amp-
lifier (Colbourn Instruments, Lehigh Valley, PA; model
V75-01). The EEG was amplified (factor of 5,000) and
analog bandpass filtered between 0.1 and 40 Hz (fre-
quency response: ±3 dB; filter frequency roll off: 12 dB /
octave). Gross body movements were detected by custom-
made infrared-based motion detectors (Biobserve GmbH,
Germany), and the movement activity was converted to a
voltage output, which was digitized and integrated into 1-s
bins. These conditioned signals (EEGs and gross body
movements) were subjected to analog-to-digital conversion
with 16-bit precision at a sampling rate of 128 Hz (NI PCI-
6033E; National Instruments, Austin, TX). The digitized
EEG waveform and integrated values for body movement
were stored as binary computer files pending subsequent
analyses.
Postacquisition determination of the vigilance state was
done by visual scoring of 12-s epochs using custom soft-
ware (ICELUS, Mark R. Opp) written in LabView for
Windows (National Instruments). The animal’s behavior
was classified as either NREM sleep, REM sleep or waking
based on previously defined criteria [27]. Briefly, NREM
sleep is characterized by large-amplitude EEG slow waves,
high power density values in the delta frequency band
(0.5 – 4.0 Hz), and lack of gross body movements. During
REM sleep, the amplitude of the EEG is reduced, the pre-
dominant EEG power density occurs within the theta
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twitches. During waking, the rats are generally active.
There are protracted body movements. The amplitude of
the EEG is similar to that observed during REM sleep, but
power density values in the delta frequency band are gen-
erally greater than those in theta frequency band.
Statistical analyses for experiment protocol
All values acquired from sleep-wake recording were pre-
sented as the mean ± SEM for the indicated sample sizes.
One-way ANOVA for the duration of each vigilance
state (NREM sleep, REM sleep, WAKE) was performed,
comparing the effects of different manipulations be-
tween groups, across the certain of time block. If statis-
tically significant differences were detected, a Fisher’s
post-hoc comparison was made to determine which
values during experimental conditions deviated from
those obtained from the control condition. An α level of
p < 0.05 was considered as indicating a statistically sig-
nificant difference.
Results
The effect of 100 Hz EA stimulation of bilateral Feng-Chi
acupoints on sleep in normal rats
High-frequency (100 Hz) EA stimulation of bilateral Feng-
Chi acupoints did not significantly alter both NREM sleep
and REM sleep during the dark period (Figure 1A, 1B &
2A), except that there were decreases of NREM sleep and
REM sleep during the first 4 hours of the dark period after
EA stimuli. Our previous results have demonstrated that
anesthetization of rats for 30 minutes with ketamine, an
NMDA receptor antagonist, prior to the dark period
suppressed both NREM sleep and REM sleep during the
first few hours of the dark period [10,30]. Therefore, the
decreases of NREM sleep and REM sleep during the
first 4 hours of the dark period, when rats received the
100 Hz EA stimulation of bilateral Feng-Chi acupoints
and were under anesthetization (the EA group), were pri-
marily due to the effect of ketamine (Figure 1A & 1B).
Our previous results have also demonstrated that EA
stimulation of bilateral Anmian acupoints under the
same method as this current experimental design en-
hances sleep during the hours 5-12 of the dark period
[10,11,30]. We further compared the values obtained
from rats received 100 Hz EA of Feng-Chi acupoints with
that acquired from undisturbed baseline during the hours
of 5-12 of the dark period, and found there was no statis-
tically significant changes in both NREM sleep and REM
sleep (Figure 2B & 2E). The percentage of time spent
in NREM sleep during hours 5-12 obtained from the
undisturbed baseline and from the rats with EA stim-
uli was 20.0 ± 2.2% and 26.1 ± 3.0% (p > 0.05; Figure 2B),
respectively. Nevertheless, REM sleep during the follow-
ing light period was decreased from 15.3 ± 1.3% obtainedfrom the undisturbed baseline to 11.5 ± 1.1% acquired
from rats treated with 100 Hz EA stimuli (p < 0.05,
Figure 2F). There was no change, except that the sleep
suppression caused by ketamine during the first 4-h post-
administration, in the sleep-wake activity when rats re-
ceived the sham EA stimulation (the sham group, Figure 1A
& 1B), which is consistent with our previous results
[11,30]. This observation indicated that high-frequency EA
stimulation of bilateral Feng-Chi acupoints did not alter
NREM sleep, but decreased REM sleep during the light
period in normal rats.The effect of administration of pilocarpine into the left
CeA on sleep
Administration of pilocarpine into the left CeA induced
focal epilepsy, which has been validated by analyzing ep-
ileptiform EEGs recorded from the frontal, parietal, oc-
cipital cortices of the left and right hemispheres in our
preliminary study. The occurrences of epileptiform EEGs
were observed during the dark period and during the
following light period. Administration of pilocarpine into
the CeA at the beginning of the dark period did not sig-
nificantly change the amounts of NREM sleep and REM
sleep during the dark period; however, both NREM sleep
and REM sleep were significantly decreased during the
following 12-h light period (Figure 1C & 1D). The per-
centage of time spent in NREM sleep during the light
period was decreased from 50.5 ± 1.9% obtained from un-
disturbed rats to 33.8 ± 3.2% acquired after administra-
tion of pilocarpine (the pilocarpine group) at the dark
onset (p < 0.05, Figure 2C), and the amount of REM sleep
during the light period was also reduced from 15.3 ± 1.3%
to 8.9 ± 1.0% (p < 0.05, Figure 2F).The effect of 100 Hz EA stimulation of bilateral Feng-Chi
acupoints on pilocarpine-induced sleep alterations
Rats received a 30-min 100 Hz EA stimulation of bilat-
eral Feng-Chi acupoints in three consecutive days did
not prevent pilocarpine-induced sleep reduction; in con-
trast, it worsened the sleep disruptions (Figure 1C & 1D).
The percentage of time spent in NREM sleep during the
dark period was significantly decreased from 16.5 ± 2.2%
obtained from the pilocarpine group to 7.4 ± 1.4% ac-
quired from the PFS + EA + pilocarpine group (p < 0.05,
Figure 2A), and the amount of REM sleep was also signifi-
cantly reduced from 4.8 ± 1.0% to 1.4 ± 0.1% (p < 0.05,
Figure 2D). The percentage of time spent in NREM sleep
during the light period was significantly decreased from
33.8 ± 3.2% obtained from the pilocarpine group to 16.4 ±
2.8% acquired from the PFS + EA + pilocarpine group
(p < 0.05, Figure 2C), and the amount of REM sleep was
also significantly reduced from 8.9 ± 1.0% to 4.1 ± 1.0%
(p < 0.05, Figure 2F).
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Figure 1 The effects of 100 Hz EA stimulation and pilocarpine in sleep. Panels A & B: NREM sleep and REM sleep obtained from the
undisturbed baseline, shame EA group and EA group. Panel C & D: NREM sleep and REM sleep acquired from the baseline, the pilocarpine group
and the PFS + EA + pilocarpine group. Black circles: the values obtained from undisturbed rats (baseline); black triangles: the values obtained from
the sham EA group; open diamonds: the values acquired from the EA group; open circles: the values obtained from the pilocarpine group; open
triangles: the data acquired from the PFS + EA + pilocarpine group. *: p < 0.05 vs. baseline. Black bar: the dark period; white bar: the light period.
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sleep alterations
Administration of naloxone significantly blocked the
100 Hz EA-induced reductions of NREM sleep and
REM sleep during both the dark period and light period
(Figure 3A & 3B). The percentage of time spent in
NREM sleep and REM sleep during the dark period ob-
tained from the naloxone + EA + pilocarpine group signifi-
cantly increased to 20.7 ± 2.0% (p < 0.05, when compared
with the values obtained from the PFS + EA + pilocarpine
group) and 5.4 ± 1.1% (p < 0.05, when compared with the
values obtained from the PFS + EA + pilocarpine group),
respectively (Figure 4A & 4D). The percentage of time
spent in NREM sleep and REM sleep during the light
period obtained from the naloxone + EA + pilocarpine
group significantly increased to 39.4 ± 1.8% (p < 0.05,
when compared with the values obtained from the PFS +
EA + pilocarpine group) and 10.7 ± 1.0% (p < 0.05, whencompared with the values obtained from the PFS + EA +
pilocarpine group), respectively (Figure 4C & 4F).
Our results also demonstrated that administration of
naloxone into the CeA did not change sleep activities
in naïve rats. The percentage of time spent in NREM
sleep during the dark period obtained from rats re-
ceived PFS and naloxone was 18.6 ± 1.6% and 21.6 ±
1.5% (p = 0.160), respectively. The percentage of time
spent in REM sleep during the dark period obtained
from rats received PFS and naloxone was 6.0 ± 0.8% and
5.2 ± 0.7% (p = 0.474), respectively. The percentage of
time spent in NREM sleep during the light period ob-
tained from rats received PFS and naloxone was 45.9 ±
1.7% and 46.1 ± 1.6% (p = 0.921), respectively. The per-
centage of time spent in REM sleep during the light
period obtained from rats received PFS and naloxone
was 7.4 ± 0.7% and 8.1 ± 0.8% (p = 0.531), respectively.
Naloxone also exhibited no significant effect on sleep-
A B C
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Figure 2 The summary of the effects of 100 Hz EA stimulation and pilocarpine in sleep. The bars from the left to the right in each panel
represent the data acquired from the baseline, the EA group, the pilocarpine group and the PFS + EA + pilocarpine group. Panels A, B and C
represent the percentage of time spent in NREM sleep during the 12-h dark period, the time block between 5-12 h of the dark period, and the
12-h light period, respectively. Panels D, E and F indicate the percentage of time spent in REM sleep during the 12-h dark period, the time block
between 5-12 h of the dark period, and the 12-h light period, respectively. **: p < 0.01.
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pilocarpine administration (data not shown). These ob-
servations suggest that the EA-induced exacerbation of
sleep disruptions was specifically mediated by opioid
receptors.
The effect of naloxonazine on the 100 Hz EA-induced
sleep alterations
Administration of naloxonazine exhibited a similar effect
to that of naloxone in blocking the 100 Hz EA-induced
reductions of NREM sleep and REM sleep during both
the dark period and light period (Figure 3C & 3D).
The percentage of time spent in NREM sleep and REM
sleep during the dark period obtained from the naloxona-
zine + EA + pilocarpine group significantly increased to
26.9 ± 2.2% (p < 0.05, when compared with the values ob-
tained from the PFS + EA + pilocarpine group) and 4.4 ±
0.8% (p < 0.05, when compared with the values ob-
tained from the PFS + EA + pilocarpine group), respectively
(Figure 4A & 4D). The percentage of time spent in NREM
sleep and REM sleep during the light period obtained from
the naloxonazine + EA + pilocarpine group significantly in-
creased to 45.7 ± 1.9% (p < 0.05, when compared with the
values obtained from the PFS + EA + pilocarpine group)and 9.3 ± 0.8% (p < 0.05, when compared with the values
obtained from the PFS + EA + pilocarpine group), respect-
ively (Figure 4C & 4F).
The effect of naltrindole on the 100 Hz EA-induced
sleep alterations
Administration of naltrindole also exhibited a similar ef-
fect to those of naloxone and naloxonazine in blocking
the 100 Hz EA-induced reductions of NREM sleep and
REM sleep during both the dark period and light period
(Figure 3E & 3F). The percentage of time spent in
NREM sleep during the dark period obtained from
the naltrindole + EA + pilocarpine group significantly in-
creased to 18.6 ± 2.3% (p < 0.05, when compared with the
values obtained from the PFS + EA + pilocarpine group).
The amount of REM sleep during the dark period ob-
tained from the naltrindole + EA + pilocarpine group in-
creased to 2.7 ± 0.6%, although it did not reach statistical
significance (p > 0.05, when compared with the values ob-
tained from the PFS + EA + pilocarpine group) (Figure 4A
& 4D). The percentage of time spent in NREM sleep and
REM sleep during the light period obtained from the nal-
trindole + EA + pilocarpine group significantly increased





Figure 3 The effects of naloxone, naloxonazine, naltrindole and nor-binaltorphimine on the EA-induced exacerbation of sleep disruptions
in rats with focal epilepsy. Panels A & B: the effects of naloxone on EA-induced disruptions of NREM sleep and REM sleep. Panels C & D: the effects
of naloxonazine on EA-induced disturbances of NREM sleep and REM sleep. Panels E & F: the effects of naltrindole on EA-induced disruptions of NREM
sleep and REM sleep. Panels G & H: the effects of nor-binaltorphimine on EA-induced disturbances of NREM sleep and REM sleep. Black circles: the data
obtained from the PFS + EA + pilocarpine group; black triangles: the values acquired from the naloxone + EA + pilocarpine group; open circles: the
results obtained from the naloxonazine + EA + pilocarpine group; open diamonds: the data acquired from the naltrindole + EA + pilocarpine group; open
triangles: the values obtained from the nor-binaltorphimine + EA + pilocarpine group. *: p < 0.05 vs. the values obtained from the PFS + EA + pilocarpine
group. Black bar: the dark period; white bar: the light period.
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9.2 ± 0.9% (p < 0.05, when compared with the values ob-
tained from the PFS + EA + pilocarpine group), respectively
(Figure 4C & 4F).The effect of nor-binaltorphimine on the 100 Hz EA-induced
sleep alterations
Administration of nor-binaltorphimine also significantly
blocked the 100 Hz EA-induced reductions of NREM
A B C
D E F
Figure 4 The summary of the effects of naloxone, naloxonazine, naltrindole and nor-binaltorphimine on the EA-induced exacerbation
of sleep disruptions. Panels A, B and C demonstrate the percentage of NREM sleep acquired from the indicated time blocks. Panels D. E and F
depict the percentage of REM sleep obtained from the indicated time blocks. The bars from the left to the right in each panel represent the
data acquired from the PFS + EA + pilocarpine group, the naloxone + EA + pilocarpine group, the naloxonazine + EA + pilocarpine group, the
naltrindole + EA + pilocarpine and the nor-binaltorphimine + EA + pilocarpine group. Panels A, B and C represent the percentage of time spent
in NREM sleep during the 12-h dark period, the time block between 5-12 h of the dark period, and the 12-h light period, respectively. Panels D, E and F
indicate the percentage of time spent in REM sleep during the 12-h dark period, the time block between 5-12 h of the dark period, and the 12-h light
period, respectively. **: p < 0.01 vs. the values acquired from the PFS + EA + pilocarpine group.
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light period (Figure 3G & 3H). The percentage of time
spent in NREM sleep and REM sleep during the dark
period obtained from the nor-binaltorphimine + EA +
pilocarpine group significantly increased to 19.0 ± 2.3%
(p < 0.05, when compared with the values obtained from
the PFS + EA + pilocarpine group) and 5.4 ± 0.8% (p < 0.05,
when compared with the values obtained from the PFS +
EA + pilocarpine group), respectively (Figure 4A & 4D).
The percentage of time spent in NREM sleep and REM
sleep during the light period obtained from the nor-
binaltorphimine + EA + pilocarpine group significantly in-
creased to 33.2 ± 2.4% (p < 0.05, when compared with the
values obtained from the PFS + EA + pilocarpine group)
and 10.2 ± 1.1% (p < 0.05, when compared with the values
obtained from the PFS + EA + pilocarpine group), respect-
ively (Figure 4C & 4F).
Discussion
Both temporal lobe epilepsy and status epilepticus are
well established in rodents by systemic or intracerebraladministration of high-dose piloparpine, a cholinergic
muscarinic agonist [31]. Several brain regions, such as the
amygdala, thalamus, olfactory cortex, hippocampus, neo-
cortex, and substantial nigra, are damaged following con-
vulsion induced by pilocarpine [31]. In fact, the interest
of relation between cholinergic mechanism and epilepsy
began when epileptic activities occurred in rats or mice
after intraamygdaloid administration of high doses of
muscarinic cholinergic agonists. Administration of betha-
nechol, a potent muscarinic agonist resistant to acetyl-
cholinesterases, into amygdala develops epileptiform EEGs,
which started in the amygdala and spread to the hippo-
campus and cortex [32]. The purpose of current study
was focused on the effect of EA on focal epilepsy and its
sleep disruptions, therefore, we administered low dose
of pilocarpine into the CeA to induce focal epilepsy.
This focal epilepsy has been validated in our preliminary
study.
Acupuncture and electroacupuncture (EA) has been
recommended as an alternative medicine for several
therapeutic indications by the World Health Organization
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tion and management of insomnia. The clinical therapeutic
effects and the underlying mechanisms of EA in pain relief
has been well elucidated; however, its effects in other as-
pects, such as neurodegenerative diseases, insomnia and
epilepsy, has been less investigated. Feng-Chi acupoint
(GB 20), located in the depression between the upper
portion of m. sternocleidomastoideus and m. trapezius in
humans, has been documented in the Lingshu Jing (the
Classic of the Miraculous Pivot) and indicated the thera-
peutic effects in headache, dizziness, hypertension, insom-
nia and epilepsy. It is commonly observed that there
are sleep disruptions, such as daytime somnolence and/or
nighttime insomnia, in patients with epilepsy [3,4]. We
previously elucidated that kindled epilepsy occurred at dif-
ferent zeitgeber times (ZTs) alters sleep differently; ZT0
kindled epilepsy decreases NREM sleep and REM sleep,
and ZT13 kindling, on the other hand, increases NREM
sleep [5,6] in experimental animals. Whereas, ZT6 kindled
epilepsy alters sleep circadian rhythm [6]. Furthermore,
epilepsy-induced sleep disruptions would further deterior-
ate and worsen the seizure control [7]. Therefore, if a ther-
apy possesses both epilepsy suppression and improvement
of sleep disturbance, it would be the most appropriate ther-
apy for seizure control. EA stimulation of bilateral Feng-
Chi acupoints may become a potential therapy to suppress
epileptic activity and improve epilepsy-induced sleep dis-
ruptions according to the documentation in the Lingshu
Jing. In this study, administration of pilocarpine into the
CeA induced focal epilepsy and decreased both NREM
sleep and REM sleep during the following light period.
However, our observation demonstrated that 100 Hz EA
stimulation of bilateral Feng-Chi acupoints exacerbates
pilocarpine-induced focal epilepsy, suggesting no beneficial
effect of EA stimulation against epileptic activity. Further-
more, we also found that 100 Hz EA stimulation of Feng-
Chi acupoints per se induces epileptiform EEGs. The
effects of high-frequency EA stimulation of Feng-Chi acu-
points on epileptic induction is a specific action, because
100 Hz EA stimulation of Anmian acupoints, which are
located near by the Feng-Chi acupoints, did not exhibit
epileptic activity [11]. In present study, we further investi-
gated the role of EA stimulation of bilateral Feng-Chi acu-
points in normal rats and in rats with pilocarpine-induced
sleep disruptions. Our results indicated that 100 Hz stimu-
lation of bilateral Feng-Chi acupoints elicited no signi-
ficant effect in the physiological sleep in normal rats,
whereas EA stimuli further deteriorated pilocarpine-
induced decreases of NREM sleep and REM sleep. Refer-
ring to our previous finding that 100 Hz EA stimulation
of Anmian acupoints, which locate near by the Feng-
Chi acupoints, enhances physiological sleep in normal
rats [11], suggesting the effect of high-frequency EA of
Feng-Chi acupints involves a specific mechanism. Theseobservations, since they subvert the functions of Feng-
Chi acupoints documented in the Lingshu Jing, surprise
us. The possible reasons of contradiction between our
findings and the documentation in Lingshu Jing are as
follows. First, with or without delivering electrical cur-
rents into Feng-Chi acupoints is a fact. The effects of epi-
leptic suppression and insomnia treatment documented
in Lingshu Jing is manipulated by dry needling, whereas
the exacerbation of pilocarpine-induced sleep disruptions
we observed in this study was the results after EA with
delivering currents into acupoints. Second, different stimu-
lation frequencies may differ the outcomes. It is worthy to
investigate the effect of different EA stimulation frequen-
cies, especially for the lower frequency (e.g., 10 Hz), on
pilocarpine-induced sleep disturbances. The last reason
might be due to the outcome was measured from rats in
current study, whereas the effect documented in Lingshu
Jing is evaluated from humans. Nevertheless, the medical
indications of the acupoints stated in the ancient Chinese
literatures need to provide further scientific evidence to
prove their therapeutic effects.
People might consider that both epilepsy and sleep dis-
ruption are pilocarpine-induced accompanying symptoms.
It is difficult to elucidate whether sleep disturbance is due
to pilocarpine per se or epilepsy consequence, since epi-
lepsy always occurred when pilocarpine administered.
However, our previous studies demonstrated the distinct
sleep disturbances induced by amygdaloid kindling at dif-
ferent zeitgeber times [5,6], suggesting the role of epilepsy
on sleep disruptions. Our current study elucidated that EA
exacerbated sleep disturbance induced by pilocarpine, re-
gardless of considering the cause(s) of sleep disruption.
Endogenous opioid peptides (e.g., encephalin, β-
endorphin, dynorphin and endormorphin) and their re-
ceptors, such as μ-, δ- and κ-opioid receptors, mediate the
most effect of acupuncture, especially in the acupuncture-
induced analgesia. Han and his colleagues have revealed
that low-frequency (2 Hz) EA stimuli increase met-
enkephalin, but not dynorphin, in the spinal cord; while
high-frequency (100 HZ) EA stimuli increase the release
of dynorphin rather than that of met-enkephalin [33].
The stimulation of EA between low and high frequency
(e.g. 15 Hz) activates both enkephalins and dynorphins
[33]. They further demonstrated that the analgesic effect
induced by low-frequency EA stimulation is mediated by
μ- and/or δ-opioid receptors; in contrast, high-frequency
EA-induced analgesia is mediated by κ-opioid recep-
tors [22,23]. We have elucidated that μ-receptors in the
NTS mediate the sleep enhancements induced by low-
frequency (10 Hz) EA stimulation of bilateral Anmian acu-
points, whereas the activation of κ-receptors contributes to
the high-frequency (100 Hz) EA-induced sleep increases
[10,11,30]. Because the amygdala is the epileptic focus in
current animal model and plays an important role in the
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ment of CeA opioid receptors in the EA-induced deterior-
ation of sleep disruptions in rats with focal epilepsy. The
dense localization of opioid receptors has been found in
the amygdala [34,35]. Although drowsiness and reduced
arousal are commonly observed after administration of
opiates [36], morphine paradoxically increases the time
spent in wakefulness and decreases the time spent in REM
sleep in humans [37,38]. Oral administration of morphine
or methadone significantly reduces slow wave sleep and in-
creases stage 2 of NREM sleep [39]. Opioid receptors me-
diate opiate-induced sleep disruptions [40,41]. Our results
demonstrated that microinjection of naloxone, nalox-
onazine, naltrindole or nor-binaltorphimine significantly
blocked 100 Hz EA stimulation-induced exacerbation of
sleep disruption in the rats with focal epilepsy, suggesting
the role of amygdaloid opioid receptors, including the μ-
receptors, δ-receptors and κ-receptors, in the effect of
high-frequency EA stimulation. A strategy of employing
pharmacological blockade to elucidate the involvement of
particular opioid receptors in 100 Hz EA-induced sleep al-
teration is appropriate. However, it would be of interest to
mimic the EA-induced sleep alteration by microinjection
of opioid receptor agonists, e.g. β-endorphin, enkephalin
and dynorphin, into the CeA in the future studies. The
role of amygdala on arousal and wakefulness has been em-
phasized. Electrical stimulation of CeA suppresses delta
wave activity in the frontal cortex and increases neocor-
tical arousal [42]. Although our result demonstrated that
administration of naloxone into CeA did not alter sleep
activities in naïve rats, opioids could inhibit both excitabil-
ity of pyramidal cells [43] and GABAergic interneurons
[44] in the CeA. We herein hypothesized that the EA-
induced exacerbation of sleep disruption may be mediated
by augmented release of endogenous opiates inhibiting
CeA GABAergic interneurons. However, it needs to be
confirmed in future study. Nevertheless, considering
together with our observation that the activation of amyg-
daloid opioid receptors by 100 Hz EA stimulation de-
teriorates pilocarpine-induced focal epilepsy, the possible
reasons for 100 Hz EA of bilateral Feng-Chi acupoints to
further deteriorate pilocarpine-induced sleep disruptions
may be either due to the effect of EA on epilepsy exacer-
bation or due to the effect of EA on sleep per se mediated
by amygdala opioid receptors, or both. It needs to be fur-
ther clarified in the future study.
In order to perform the 100 Hz EA stimulation easily,
rats were lightly anesthetized. Our previous and present
results indicated that both NREM sleep and REM sleep
during the first few hours of the dark period were de-
creased after rats recovered from the ketamine anesthetic.
The decreases in NREM sleep and REM sleep were also
observed in our previous study [10,11]. Ketamine, a cyclo-
hexanone derivative, is used clinically as a dissociativeanesthetic agent both in humans and animals. Ketamine is
a noncompetitive N-methyl-D-aspartate (NMDA) receptor
antagonist that blocks cation channels [45]. It has been
demonstrated that administration of ketamine or MK-801,
another NMDA receptor antagonist, at sub-anesthetic
doses produces a robust, dose-dependent increase in the
intensity of δ-power of the NREM sleep [46,47]. Further-
more, the effect of MK-801 by increasing the metabolic
rate in the hippocampus and other limbic structures stimu-
lates physiological sleep that is similar to the sleep that fol-
lows sleep deprivation, indicating the need of homeostatic
recovery [48]. Therefore, the suppression of NREM and
REM sleep after recovery from ketamine anesthetization
during the beginning of the dark period may be due to a
homeostatic compensation to the previous anesthetic state.
However, this explanation needs to be further investigated.
Conclusions
In summary, our current results indicated that high-
frequency (100 Hz) EA stimulation of bilateral Feng-Chi
acupoints deteriorated pilocarpine-induced sleep disrup-
tions. The EA-induced exacerbation of sleep disruptions
was blocked by administration of μ-, δ-, or κ-opioid recep-
tor antagonist into the CeA, demonstrating the involve-
ment of CeA opioid receptors. Our current results suggest
that 100 Hz EA stimulation of bilateral Feng-Chi acupoints
did not exhibit the beneficial effect against sleep distur-
bances in rats with focal epilepsy, whereas it further deteri-
orated sleep.
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